Roxybond
Payments companies reported to CMS as associated with Roxybond. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Roxybond, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Roxybond
These are the largest totals companies reported as associated with Roxybond. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Rosenfeld | Covington, GA | Interventional Pain Medicine | $1,888.26 |
| Alexander Weingarten | Syosset, NY | Interventional Pain Medicine | $1,359.57 |
| Russell Feit | Palm Beach Gardens, FL | Pain Medicine (Anesthesiology) | $1,299.14 |
| Alexander Beyzer | Saint Louis, MO | Pain Medicine | $1,211.53 |
| J Carvel Jackson | Mesa, AZ | Addiction Medicine (Internal Medicine) | $1,196.22 |
| Amy Berkhout | Chandler, AZ | Family | $1,152.66 |
| Romanth Waghmarae | Hamburg, NY | Pain Medicine (Anesthesiology) | $1,096.45 |
| Ramesh Singa | Austin, TX | Pain Medicine (Anesthesiology) | $1,094.36 |
| Sheri Couch | Forest City, NC | Nurse Practitioner | $957.99 |
| Eli Djebiyan | Englewood, NJ | Internal Medicine | $801.44 |
Prescribed Roxybond?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.